TGF-β1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis

International Journal of Cancer

Volumn 84, Issue 2, 1999, Pages 155-159

  Li, Chenggang ^a   Wilson, Philip B ^b   Levine, Edward ^d   Barber, Jim ^a,c   Stewart, Alan L ^c   Kumar, Shant ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BREAST CARCINOMA; BREAST INJURY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY CANCER; EXTRACELLULAR MATRIX; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RADIATION INJURY; RECEPTOR BINDING; RISK FACTOR; BLOOD; BREAST; BREAST TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSIS; IMMUNOBLOTTING; MIDDLE AGED; PATHOLOGY; RADIATION EXPOSURE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; BREAST; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; HUMANS; IMMUNOBLOTTING; MIDDLE AGED; RECEPTORS, CELL SURFACE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032589002     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990420)84:2<155::AID-IJC11>3.0.CO;2-S     Document Type: Article

References (26)

1. ANSCHER, M.S., KONG, F.M., MARKS, L.B., BENTEL, G.C. and JIRTLE, R.L., Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int. J. Radiat. Oncol. Biol. Phys., 37, 253-258 (1997).
2. ANSCHER, M.S., PETERS, W.P., REISENBICHLER, H., PETROS, W.P. and JIRTLE, R.L., Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N. Engl. J. Med., 328, 1592-1598 (1993).
3. BARCELLOS-HOFF, M.H., DERYNCK, R., TSANG, M.L. and WEATHERBEE, J.A., Transforming growth factor-β activation in irradiated murine mammary gland. J. clin. Invest., 93, 892-899 (1994).
4. BENTZEN, S.M., Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother. Oncol., 43, 121-131 (1997).
5. BLANN, A.D., WANG, J.M., WILSON, P.B. and KUMAR, S., Serum levels of TGFβ receptor are increased in atherosclerosis. Atherosclerosis, 120, 221-226 (1996).
6. BODEY, B., BODEY, B., JR., SIEGEL, S.E. and KAISER, H.E., Upregulation of endoglin (CD105) expression during childhood brain tumour-related angiogenesis. Anti-angiogenic therapy. Anticancer Res., 18, 1485-1500 (1998).
7. CHEIFETZ, S., BELLO, T., CALES, C., VERA, S., BERNABEU, C., MASSAGU, J. and LETARTE, M., Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J. biol. Chem., 267, 19027-19030 (1992).
8. EHRHART, E.J., SEGARINI, P., TSANG, M.L., CARROLL, A.G. and BARCELLOS-HOFF, M.H., Latent transforming growth factor β1 activation in situ: quantitative and functional evidence after low-dose γ-irradiation. FASEB J., 11, 991-1002 (1997).
9. GRAINGER, D.J., MOSEDALE, D.E., METCALFE, J.C., WEISSBERG, P.L. and KEMP, P.R., Active and acid-activatable TGFβ in human sera, platelets and plasma. Clin. chim. Acta, 235, 11-31 (1995).
10. KONG, F.M., ANSCHER, M.S., MURASE, T., ABBOTT, B.D., IGLEHART, J.D. and JIRTLE, R.L., Elevated plasma transforming growth factor-β1 levels in breast cancer patients decrease after surgical removal of the tumour. Ann. Surg., 222, 155-162 (1995).
11. KOTECHA, S., WANGOO, A., SILVERMAN, M. and SHAW, R.J., Increase in the concentration of transforming growth factor β1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J. Pediatr., 128, 464469 (1996).
12. KUMAR, S., WANG, J.M. and BERNABEU, C., CD105 and angiogenesis. J. Pathol., 178, 363-366 (1996).
13. LASTRES, P., LETAMENDIA, A., ZHANG, H., RIUS, C., ALMENDO, N., RAAB, U., LOPES, L.A., LANGA, C., FABRA, A., LETARTE, M. and BERNABEU, C., Endoglin modulates cellular responses to TGFβ1. J. Cell Biol., 133, 1109-1121 (1996).
14. LENT SOMA scales for all anatomic sites. Int. J. Radiat. Oncol. Biol. Phys. 31, 1049-1092 (1995).
15. LI, C.G., WILSON, P.B., BERNABEU, C., RAAB, U., WANG, J.M. and KUMAR, S., Immunodetection and characterisation of soluble CD105-TGFβ complexes. J. Immunol. Methods, 218, 85-93 (1998).
16. PICHUANTES, S., VERA, S., BOURDEAU, A., PECE, N., KUMAR, S., WAYER, E.A. and LETARTE, M., Mapping epitopes to distinct regions of the extracellular domain of endoglin (CD105) using bacterially expressed recombinant fragments. Tissue Antigens, 50, 265-276 (1997).
17. PIRCHER, R., JULLIEN, P. and LAWRENCE, D.A., Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem. biophys. Res. Comm., 136, 30-37 (1986).
18. QUARMBY, S., Kumar, P., and Kumar, S. Irradiation induced normal tissue injury: the role of adhesion molecules in leukocyte-endothelial cell interactions (review). Int. J. Cancer (in press) (1999).
19. RAAB, U., LANGA, C., LETAMENDIA, A., LASTRES, P., PAEZ, E. and BERNABEU, C., Characterisation of anti-CD105 monoclonal antibodies using recombinant vaccinia virus. In: T. Kishimoto (ed.), Leucocyte typing VI, Garland, New York (1997) pp 708-709.
20. RANDALL, K. and COGGLE, J.E., Expression of transforming growth factor-β1 in mouse skin during the acute phase of radiation damage. Int. J. Radiat. Biol., 68, 301-309 (1995).
21. RANDALL, K. and COGGLE, J.E., Long-term expression of transforming growth factor TGFβ1 in mouse skin after localized β-irradiation. Int. J. Radiat. Biol., 70, 351-360 (1996).
22. RUBIN, P., CONSTINE, L.S., FAJARDO, L.F., PHILLIPS, T.L. and WASSERMAN, T.H., Overview: late effects of normal tissues (LENT) scoring system. Int. J. Radiat. Oncol. Biol. Phys., 31, 1041-1042 (1995).
23. RUBIN, P., FINKELSTEIN, J. and SHAPIRO, D., Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int. J. Radiat. Oncol. Biol. Phys., 24, 93-101 (1992).
24. TURESSON, I., NYMAN, J., HOLMBERG, E. and ODEN, A., Prognostic factors for acute and late skin reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys., 36, 1065-1075 (1996).
25. WANG, J.M., KUMAR, S., VAN AGTHOVEN, A., KUMAR, P., PYE, D. and HUNTER, R.D., Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells. Int. J. Cancer, 62, 791-796 (1995).
26. WANG, J.M., WILSON, P.B., KUMAR, S., PYE, D. and HUNTER, R.D., Quantitation of endothelial cell specific protein E9 employing a single monoclonal antibody in an indirect sandwich ELISA. J. Immunol. Methods, 171, 55-64 (1994).